[신라젠] 투자판단관련주요경영사항(임상시험계획승인신청) (덱시부프로펜주(WS2405)의 제 1상 임상시험 계획 승인 신청)
09/15/2026
Company
신라젠· 215600
SillaJen, Inc.
Showing 5 RSS articles and DART filings mapped to this company, sorted by time.
- Market
- LISTED
- Items
- 5
2026-Q3
View on DART
[신라젠] [기재정정]주식매수선택권부여에관한신고
09/03/2026
[신라젠] [기재정정]주식매수선택권부여에관한신고
09/03/2026
[신라젠] 반기보고서 (2026.06)
08/14/2026
[신라젠] [기재정정]분기보고서 (2026.03)
08/14/2026